Almazov National Medical Research Centre
Almazov National Medical Research Centre
Saint Petersburg, Russia8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Recruiting | Phase 3 | 2025-11-18 | NCT06700096 | |
| Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. | B-cell neoplasm, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, graft versus host disease, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 4 | 2025-10-30 | NCT03229200 | |
| The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional) | Acute Ischemic Stroke, Chronobiology Disorders, Dyssomnias, Occupational Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, circadian rhythm sleep disorder, ischemic stroke, nervous system disorder, psychiatric disorder, sleep-wake disorder, stroke disorder, vascular disorder | Recruiting | Phase 4 | 2025-08-08 | NCT05247125 | |
| The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational) | Apnea, Cognition Disorders, Cognitive Dysfunction, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, ischemic stroke, nervous system disorder, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2025-08-08 | NCT05242393 | |
| Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Recruiting | Phase 1 / Phase 2 | 2025-06-13 | NCT06120582 | |
| A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-04-24 | NCT06185335 | |
| Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) | central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2025-01-31 | NCT04174157 | |
| Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients | Pulmonary Embolism Acute | Recruiting | Not applicable | 2024-07-05 | NCT06487052 |